Y-mAbs Therapeutics, Inc. earnings per share and revenue

YMAB earnings per share for the last quarter are -0.02 USD whereas the estimation was -0.20 USD which accounts for 89.80% surprise. Company revenue for the same period amounts to 23.36 M USD despite the estimated figure of 20.95 M USD. Estimated earnings per share for the next quarter are -0.14 USD, and revenue is expected to reach 22.21 M USD. Also watch annual changes over time to get a bigger picture of YMAB earnings per share and revenue dynamics.